Recent Blog Articles

Harvard Health Blog

Darolutamide approved for nonmetastatic castration-resistant prostate cancer

Published: November 22, 2019
  • Author: Charlie Schmidt,

Disclaimer:

As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

Comments

Michael
November 27, 2019

Can this work for metastatic castration resistance prostate cancer for men who have tried enzalutamide with no luck?

Jose Luksamana Jr
November 24, 2019

How about food and lifestyle as medicine? Can that be a choice, too?

Commenting has been closed for this post.